lithium has been researched along with HIV Coinfection in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Decloedt, E; Gisslén, M; Gleich, M; Hye, A; Joska, J; Koutsilieri, E; Lesosky, M; Scheller, C; Thela, L; Zetterberg, H | 1 |
Van Gaal, LF; Verhaegen, AA | 1 |
Clotet, B; Díez-Quevedo, C; Ferrer, MJ; Fumaz, CR; Garolera, M; Miranda, C; Moltó, J; Muñoz-Moreno, JA; Pérez-Álvarez, N; Prats, A | 1 |
Goldschlager, N; Treit, K; Waldo, SW | 1 |
Gallichio, VS; Harvey, BH; Manji, HK; Meyer, CL | 1 |
Bradley, J; Dewhurst, S; Dou, H; Ellison, B; Gelbard, HA; Gendelman, HE; Kasiyanov, A; Maggirwar, S; Poluektova, LY; Xiong, H | 1 |
Al-Harthi, L; Kumar, A; Moon, RT; Tenorio, AR; Watts, J; Zloza, A | 1 |
Janković, BD | 1 |
3 review(s) available for lithium and HIV Coinfection
Article | Year |
---|---|
Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an Update.
Topics: Adrenal Cortex Hormones; Animals; Anti-Retroviral Agents; Antidepressive Agents; Antipsychotic Agents; Body Fat Distribution; Body Weight; Cardiovascular Diseases; Diabetes Mellitus; HIV Infections; Humans; Insulin Resistance; Lithium; Metabolic Diseases; Obesity; Weight Gain | 2021 |
Lithium salts in AIDS and AIDS-related dementia.
Topics: AIDS Dementia Complex; Animals; HIV Infections; Humans; Lithium; Neuroprotective Agents | 2002 |
The neuro-immune network. Some recent developments.
Topics: Animals; Autoantibodies; Brain; Enkephalins; Heroin Dependence; HIV Infections; Humans; Hypersensitivity, Delayed; Immune System; Lithium; Magnetics; Nervous System Diseases; Neuroimmunomodulation | 1992 |
2 trial(s) available for lithium and HIV Coinfection
Article | Year |
---|---|
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial.
Topics: Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Dopamine; Glycogen Synthase Kinase 3; HIV; HIV Infections; Humans; Lithium; Middle Aged | 2023 |
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.
Topics: Administration, Cutaneous; Adult; Anti-Retroviral Agents; Cognitive Dysfunction; Executive Function; Female; HIV Infections; Humans; Lithium; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Pilot Projects; Rivastigmine; Treatment Outcome | 2017 |
3 other study(ies) available for lithium and HIV Coinfection
Article | Year |
---|---|
Possible acute myocardial infarction in a hypothermic patient.
Topics: Acute Disease; Anticonvulsants; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Drug Overdose; HIV Infections; Humans; Hypothermia; Lamotrigine; Lithium; Male; Middle Aged; Myocardial Infarction; Seizures; Trazodone; Triazines | 2011 |
Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis.
Topics: Abortion, Induced; Animals; Brain; Cells, Cultured; Disease Models, Animal; Encephalitis, Viral; Fetus; HIV Infections; HIV-1; HIV-2; Humans; Lithium; Macrophages; Male; Mice; Mice, SCID; Monocytes; Neurons | 2005 |
Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells.
Topics: beta Catenin; Enzyme-Linked Immunosorbent Assay; HIV; HIV Infections; Humans; Lithium; Monocytes; Signal Transduction; Viral Load; Virus Activation; Virus Latency; Virus Replication | 2008 |